Arbutus Biopharma (NASDAQ:ABUS) appoints William H. Collier as President, Chief Executive Officer (CEO) and member of the Board of Directors, effective June 24.
Mark J. Murray, Ph.D., will retire from his position of President, CEO and Board member on June 23rd.
Mr. Collier, previously served as President and General Manager, North America at ViiV Healthcare.